Per-Se Technologies, Inc. announced that it expects consolidated fiscal 2006 revenue to be in the range of $625 - $635 million. The expected fiscal 2006 and the pro forma 2005 revenue and operating income reflect adjustments for elimination of revenues between Per-Se and NDCHealth, and consistent purchase accounting adjustments for both periods. Due to accretion from its acquisition of NDCHealth, the Company raised its fiscal 2006 adjusted diluted earnings per share (EPS) expectations to a range of $1.30 to $1.40.

Adjusted diluted EPS guidance for fiscal 2006 excludes expected transition and integration-related costs related to the NDCHealth merger, an in-process R&D write-off expense, any further partial release of the Company's deferred tax asset valuation allowance, and stock-based compensation expense. The Company's fiscal 2006 adjusted diluted EPS guidance excludes the estimated impact of adopting Statement of Financial Accounting Standards (SFAS) No. 123 (R), Share-Based Payment.

The Company expects to incur an additional non-cash expense related to the adoption of SFAS 123 (R) of approximately $8 - $9 million, or $0.18 - $0.21 per diluted share, which includes expenses related to stock-based compensation grants expected in 2006. Adjusted EBITDA for fiscal 2006 is expected to be in the range of $142 - $147 million. The Company expects EPS from continuing operations of $0.17 to $0.20 in the first quarter 2006 and $0.30 to $0.33 in the second quarter 2006.

Per Se acquired NDCHealth in a deal approved by shareholders in early January of this year.